{"id":171879,"date":"2017-12-19T18:49:01","date_gmt":"2017-12-19T18:49:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=171879"},"modified":"2017-12-19T18:49:01","modified_gmt":"2017-12-19T18:49:01","slug":"breast-biopsy-devices-market-regulations-size-share-and-competitive-landscape-outlook-to-2022-credence-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/breast-biopsy-devices-market-regulations-size-share-and-competitive-landscape-outlook-to-2022-credence-research_171879.html","title":{"rendered":"Breast Biopsy Devices Market Regulations, Size, Share and Competitive Landscape Outlook to 2022: Credence Research"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Breast Biopsy Devices Market”<\/div>\n<\/div>\n<\/div>\n
The global breast biopsy devices market is consolidated with a few players dominating the major chunk of the market revenue. <\/div>\n

The latest market report published by Credence Research “Global Breast Biopsy Devices Market<\/a> – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the breast biopsy devices market was valued at USD 617.62 Mn in 2015, and is expected to reach USD 1,250.71 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.<\/p>\n

Browse the full report Breast Biopsy Devices Market<\/strong> – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http:\/\/www.credenceresearch.com\/report\/breast-biopsy-devices-market<\/a><\/p>\n

Market Insights<\/strong>
Breast cancer is among the most commonly diagnosed non-skin cancer across the world, with among the highest annual mortality. While the incidence of the disease is increasing at alarming rates in the developing markets, the breast cancer survival prognosis is reported to be con tenuously improving this proving development in the trends of early disease diagnosis and treatment outcomes. Pathological detection of breast cancer has evolved a long way until present with biopsy becoming the standard route of disease detection. With the introduction of minimally invasive biopsy procedures, intimating with fine needle aspiration, the global breast biopsy devices market has witnessed phenomenal growth over the period. Rapidly aging population and the proven correlation of age with the incidence of breast cancer is among the biggest contributors to the breast biopsy devices market. Alarming disease incidence and technological development resulting in rapid adoption of breast biopsy devices and related solutions are observed to be the major market drivers in the developing regions of the world. Introduction of guidance enabled biopsy systems has further facilitated the market development and assisted in containment of breast cancer incidence.<\/p>\n

Market Competition Assessment<\/strong><\/p>\n

The global breast biopsy devices market is consolidated with a few players dominating the major chunk of the market revenue. Players such as Hologic, Mammotome, C.R. Bar, Inc. are identified and recognized as the global market leaders. Other players such as Argon Medical Devices, Becton Dickinson, and Company, Sterylab are the promising market players with their established positions in prime market segments.<\/p>\n

Key Market Movements<\/strong><\/p>\n